Symptom–Sign Discordance in Dry Eye Disease: Clinical Characteristics and Age-Adjusted Ocular Surface Findings

The human eye is a delicate instrument that relies on a thin, constantly renewing film of tears to stay clear and comfortable. When this system falters, a condition known as dry eye disease takes hold. It is not merely a matter of the eye feeling scratchy; it is a complex disorder where the tear film becomes unstable, the surface of the eye can become inflamed, and the nerves that sense the eye's condition may misfire. For decades, doctors have tried to diagnose this problem by looking at two different things: what the patient says they feel, and what the doctor sees when they examine the eye. Often, these two sources of information tell very different stories. A patient might describe a burning, gritty sensation that seems unbearable, yet the doctor sees an eye that looks relatively healthy under the microscope. Conversely, another patient might have an eye that looks severely damaged and dry, yet they report feeling almost no discomfort. This mismatch between feeling and appearance is a common puzzle in eye care, leaving clinicians unsure whether to treat the visible damage or the invisible pain.

Researchers at Mersin City Training and Research Hospital in Turkey set out to untangle this specific confusion. They gathered a group of 120 adults who had come to their clinic complaining of dry eye symptoms. Before looking at their eyes, the team asked these patients to fill out detailed questionnaires about how often they felt discomfort and how severe it was. Then, the doctors performed a thorough, standardized examination. They measured how long the tear film stayed intact before breaking up, checked the height of the tear line along the eyelid, and used a special dye to see if the surface of the eye was scratched. Crucially, they also looked deep inside the eyelids using infrared imaging to see the structure of the oil glands that keep tears from evaporating too quickly, and they tested how well those glands could squeeze out their oily secretion. By combining the patients' self-reported feelings with these objective measurements, the team sorted everyone into four distinct groups: those with high symptoms and high signs, those with low symptoms and low signs, and two groups where the feelings and the facts did not match.

The study revealed that this mismatch is far from rare. Nearly half of the patients, specifically 41.7 percent, fell into one of the discordant categories. About a quarter of the group suffered from severe symptoms even though their eyes showed only mild physical signs of damage. Another group, representing roughly 18 percent of the patients, had eyes that looked significantly damaged but reported feeling relatively fine. When the researchers looked closer at the group with severe symptoms but mild signs, they found a specific clue: while the structure of the oil glands looked mostly intact, the quality of the oil they produced was poor, and the glands struggled to squeeze it out. This suggests that for these patients, the problem lies in how the glands function rather than how many of them are missing. The oil they produce is likely too thick or sticky to spread properly, causing the tears to evaporate and the eye to feel irritated, even if the glands themselves have not yet collapsed.

In contrast, the group with damaged eyes but few symptoms told a different story. These individuals were significantly older than the others, and their oil glands showed much greater structural loss. When the researchers adjusted their analysis to account for age, the difference in gland loss between the groups became less distinct. This indicates that the severe structural damage seen in the older, low-symptom group is likely a natural consequence of aging rather than a specific sign of a mismatched disease state. Their eyes may have adapted to the damage over time, or their nerves may have become less sensitive, allowing them to tolerate a condition that would cause severe pain in a younger person. The study suggests that the physical loss of gland tissue is a slow, cumulative process, whereas the ability of the remaining glands to function properly is what often drives the immediate feeling of discomfort.

The findings point toward a more nuanced way of understanding dry eye disease. It is not enough to simply look at how many oil glands are missing or how much the eye is stained with dye. A patient's experience is shaped by a combination of factors, including the current functional state of their oil glands and their age. For the patient who feels terrible but looks fine, the issue is likely a functional failure of the oil secretion, requiring treatments that improve how the glands work. For the patient who looks bad but feels fine, the visible damage may be an age-related change that does not necessarily require aggressive intervention for pain. The researchers conclude that doctors need to use a multimodal approach, listening carefully to the patient's story while also examining both the structure and the function of the eye's oil-producing system. By doing so, they can better understand why two people with the same diagnosis might have such different experiences, and tailor their care to the specific reality of each individual's eye.